| TheraCryf (LSE:TCF) — Update on the Ox-1 programme | Tue, Oct 20, 2026 · 8:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Final Results for the year ended 31 March 2026 | Mon, Sep 28, 2026 · 8:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Investor Presentation | Fri, Apr 24, 2026 · 5:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Half year results for the six months to 30 September 2025 | Wed, Dec 03, 2025 · 6:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Ox-1 – A deep dive into TheraCryf’s addiction programme | Wed, Jun 11, 2025 · 6:30 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Half Year Results | Thu, Nov 28, 2024 · 6:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Research and Development Update | Thu, Jun 13, 2024 · 4:30 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Investor Presentation | Wed, Mar 20, 2024 · 6:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Post-AGM Q&A | Thu, Jul 20, 2023 · 11:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Preliminary pharmacokinetic results from Phase 1b study of new SFX-01 tablet formulation | Thu, Mar 23, 2023 · 10:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Interim Results 2022-23 | Thu, Dec 08, 2022 · 9:00 AM ET | Replay |
|---|
| TheraCryf (LSE:TCF) — Post AGM Presentation | Thu, Jul 21, 2022 · 10:30 AM ET | Replay |
|---|